Indication
Nephrotic syndrome
Nephrotic syndrome is a renal disorder characterized by severe glomerular dysfunction resulting from increased permeability of the glomerular filtration barrier. Read more about Nephrotic syndrome
340 drugs 164 manufacturers
Drugs that treat it
Common Nephrotic syndrome therapies.
DEXPAK (dexamethasone)
PREDNISONE
PREDNISONE
PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE SODIUM PHOSPHATE
METHYLPREDNISOLONE
METHYLPREDNISOLONE
METHYLPREDNISOLONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNephrotic syndrome is a renal disorder characterized by severe glomerular dysfunction resulting from increased permeability of the glomerular filtration barrier.
It can affect both pediatric and adult populations and arises either primarily from intrinsic kidney diseases—such as minimal change disease, focal segmental glomerulosclerosis, or membranous nephropathy—or secondarily from systemic conditions like diabetes mellitus, amyloidosis, and systemic lupus erythematosus.
Pathophysiologically, the hallmark is nephrotic-range proteinuria, typically defined as urinary protein excretion exceeding 3.5 grams per 24 hours in adults.
This profound urinary protein loss drives hypoalbuminemia, which in turn leads to oncotic fluid shifts presenting clinically as pronounced peripheral and periorbital edema, frequently accompanied by compensatory hyperlipidemia and an increased risk of thromboembolism and infection.
- nih.gov
Nephrotic syndrome is a renal disorder characterized by severe glomerular dysfunction resulting from increased permeability of the glomerular filtration barrier
- nih.gov
Nephrotic syndrome is a renal disorder characterized by severe glomerular dysfunction resulting from increased permeability of the glomerular filtration barrier
- nih.gov
It can affect both pediatric and adult populations and arises either primarily from intrinsic kidney diseases—such as minimal change disease, focal segmental glomerulosclerosis, or membranous nephropathy—or secondarily from systemic conditions like diabetes mellitus, amyloidosis, and systemic lupus erythematosus Pathophysiologically, the hallmark is nephrotic-range proteinuria, typically defined as urinary protein excretion exceeding 3.5 grams per 24 hours in adults This profound urinary protein...
- nih.gov
It can affect both pediatric and adult populations and arises either primarily from intrinsic kidney diseases—such as minimal change disease, focal segmental glomerulosclerosis, or membranous nephropathy—or secondarily from systemic conditions like diabetes mellitus, amyloidosis, and systemic lupus erythematosus
- kidney.org
It can affect both pediatric and adult populations and arises either primarily from intrinsic kidney diseases—such as minimal change disease, focal segmental glomerulosclerosis, or membranous nephropathy—or secondarily from systemic conditions like diabetes mellitus, amyloidosis, and systemic lupus erythematosus
- nih.gov
This profound urinary protein loss drives hypoalbuminemia, which in turn leads to oncotic fluid shifts presenting clinically as pronounced peripheral and periorbital edema, frequently accompanied by compensatory hyperlipidemia and an increased risk of thromboembolism and infection
- nih.gov
This profound urinary protein loss drives hypoalbuminemia, which in turn leads to oncotic fluid shifts presenting clinically as pronounced peripheral and periorbital edema, frequently accompanied by compensatory hyperlipidemia and an increased risk of thromboembolism and infection
Personalize your experience
Follow Nephrotic syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.